Article
DOR-1, A novel CD10+ stromal cell line derived from progressive Langerhans cell histiocytosis of bone.
Pediatric blood & cancer - 1 Feb 2005
Gogusev Jean, Telvi Louise, Murakami Ichiro, Lepelletier Yves, Nezelof Christian, Stojkoski Alexandre, Glorion Christophe, Jaubert Francis
Abstract excerpt
BACKGROUND: Langerhans cell histiocytosis (LCH) is granulomatous proliferative disorder characterized by the presence of activated Langerhans cells admixed with macrophages, lymphocytes, and eosinophils. In an effort to obtain an LCH ex vivo model, we succeeded in establishing the DOR-1 cell line from an LCH lesion of bone in a 3-year-old girl. PROCEDURE: The DOR-1 cell line was established from a CD1a...
Topics
- Animals
- Bone Diseases
- Cell Differentiation
- Cell Division
- Cell Line
- Child, Preschool
- Female
- Genotype
- Histiocytosis, Langerhans-Cell
- Humans
- Immunophenotyping
